C. Corne and P. Faure, Le dépistage néonatal en France : approche biologique. Rev Francoph des Lab, vol.2018, pp.30-35, 2018.

J. G. Loeber, P. Burgard, M. C. Cornel, T. Rigter, S. S. Weinreich et al., Newborn screening programmes in Europe; arguments and efforts regarding harmonization. Part 1. From blood spot to screening result, J Inherit Metab Dis, vol.35, issue.4, pp.603-614, 2012.

R. Ziadeh, E. P. Hoffman, D. N. Finegold, R. C. Hoop, J. C. Brackett et al., Medium chain Acyl-CoA dehydrogenase deficiency in pennsylvania:Neonatal screening shows highincidence and unexpected mutation frequencies, Pediatr Res, vol.37, issue.5, pp.675-683, 1995.

F. Feillet, H. Ogier, D. Cheillan, C. Aquaviva, F. Labarthe et al., Déficit en acyl-CoAdéshydrogénase des acides gras à chaîne moyenne (MCAD) : consensus français pour le dépistage, le diagnostic, et la prise en charge. Arch Pédiatrie, vol.19, pp.184-93, 2012.

S. M. Houten and R. Wanders, A general introduction to the biochemistry of mitochondrial fatty acid ?-oxidation, J Inherit Metab Dis, vol.33, issue.5, pp.469-77, 2010.

V. A. Vishwanath, Fatty Acid Beta-Oxidation Disorders: A Brief Review, Ann Neurosci, vol.23, issue.1, pp.51-56, 2016.

C. A. Stanley, D. E. Hale, P. M. Coates, C. L. Hall, B. E. Corkey et al., Medium-Chain Acyl-CoA Dehydrogenase Deficiency in Children with Non-Ketotic Hypoglycemia and Low Carnitine Levels, Pediatr Res, vol.17, issue.11, pp.877-84, 1983.

P. De-lonlay, F. Djouadi, J. Bonnefont, J. Saudubray, and J. Bastin, La ?-oxydation mitochondriale des acides gras : une voie métabolique essentielle du fonctionnement musculaire. Arch Pédiatrie, vol.9, pp.175-183, 2002.

C. J. Rebouche, Carnitine function and requirements during the life cycle, FASEB J, vol.6, issue.15, pp.3379-86, 1992.

N. Longo, M. Frigeni, and M. Pasquali, Carnitine transport and fatty acid oxidation, Biochim Biophys Acta, vol.1863, issue.10, pp.2422-2457, 2016.

B. Eaton-s, . Kb, and . Pourfarzam-m, Mammalian mitochondrial ? -oxidation

J. Biochem, , vol.320, pp.345-57, 1996.

Y. Poirier, V. D. Antonenkov, T. Glumoff, and J. K. Hiltunen, Peroxisomal ?-oxidation-A metabolic pathway with multiple functions, Biochim Biophys Acta -Mol Cell Res, vol.1763, issue.12, pp.1413-1439, 2006.

P. Janeiro, R. Jotta, R. Ramos, C. Florindo, F. V. Ventura et al., Follow-up of fatty acid ?-oxidation disorders in expanded newborn screening era, Eur J Pediatr, vol.178, issue.3, pp.387-94, 2019.

S. Thangavelu, Fatty Acid Oxidation disorders, Indian J Pract Pediatr, vol.12, issue.2, pp.181-184, 2010.

M. Wajner and A. U. Amaral, Mitochondrial dysfunction in fatty acid oxidation disorders: insights from human and animal studies, Biosci Rep, vol.36, issue.1, p.281, 2015.

V. Gartner, P. J. Mcguire, and P. R. Lee, Child Neurology: Medium-chain acyl-coenzyme A dehydrogenase deficiency, Neurology, vol.85, issue.4, pp.37-40, 2015.

N. Gregersen, R. Lauritzen, and K. Rasmussen, Suberylglycine excretion in the urine from a patient with dicarboxylic aciduria, Clin Chim Acta, vol.70, issue.3, pp.417-442, 1976.

N. Gregersen, F. Rosleff, S. Kølvraa, N. Hobolth, K. Rasmussen et al., Non-ketotic C6-C10-dicarboxylic aciduria: biochemical investigations of two cases, Clin Chim Acta, vol.102, issue.2-3, pp.179-89, 1980.

S. Kølvraa, N. Gregersen, E. Christensen, and N. Hobolth, In vitro fibroblast studies in a patient with C6-C10-dicarboxylic aciduria: evidence for a defect in general acyl-CoA dehydrogenase, Clin Chim Acta, vol.126, issue.1, pp.53-67, 1982.

A. J. Howat, M. J. Bennett, S. Variend, and L. Shaw, Deficiency of medium chain fatty acylcoenzyme A dehydrogenase presenting as the sudden infant death syndrome, BMJ, vol.288, issue.6422, pp.976-976, 1984.

C. R. Roe, D. S. Millington, D. A. Maltby, and P. Kinnebrew, Recognition of medium-chain acyl-CoA dehydrogenase deficiency in asymptomatic siblings of children dying of sudden infant death or Reye-like syndromes, J Pediatr, vol.108, issue.1, pp.13-21, 1986.

K. Tanaka, I. Yokota, P. M. Coates, A. W. Strauss, D. P. Kelly et al., Mutations in the medium chain acyl-CoA dehydrogenase (MCAD) gene, Hum Mutat, vol.1, issue.4, pp.271-280, 1992.

N. Gregersen, A. Blakemore, V. Winter, B. Andresen, S. Kølvraa et al., Specific diagnosis of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in dried blood spots by a polymerase chain reaction (PCR) assay detecting a point-mutation (G985) in the MCAD gene, Clin Chim Acta, vol.203, issue.1, pp.23-34, 1991.

D. P. Kelly, A. J. Whelan, M. L. Ogden, R. Alpers, Z. F. Zhang et al., Molecular characterization of inherited medium-chain acyl-CoA dehydrogenase deficiency, Proc Natl Acad Sci, vol.87, issue.23, pp.9236-9276, 1990.

Y. Matsubara, K. Narisawa, S. Miyabayashi, K. Tada, P. M. Coates et al., Identification of a common mutation in patients with medium-chain acyl-CoA dehydrogenase deficiency, Biochem Biophys Res Commun, vol.171, issue.1, pp.498-505, 1990.

I. Yokota, K. Tanaka, P. Coates, M. Ugarte, J. Ding et al., Mutations in medium chain acyl-CoA dehydrogenase deficiency, Lancet, vol.336, issue.8717, pp.748-757, 1990.

M. J. Bennett, F. Allison, G. W. Lowther, R. G. Gray, D. I. Johnston et al., Prenatal diagnosis of medium-chain acyl-coenzyme A dehydrogenase deficiency, Prenat Diagn, vol.7, issue.2, pp.135-176, 1987.

N. Gregersen, V. Winter, P. K. Jensen, A. Holmskov, S. Kølvraa et al., Prenatal diagnosis of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in a family with a previous fatal case of sudden unexpected death in childhood, Prenat Diagn, vol.15, issue.1, pp.82-88, 1995.

K. Sermon, P. Henderix, W. Lissens, D. Vos, A. Vandervorst et al., Preimplantation genetic diagnosis for medium-chain acyl-CoA dehydrogenase (MCAD) deficiency

, Molecular Human Reproduction, vol.6, 2000.

D. H. Chace, S. L. Hillman, J. L. Van-hove, and E. W. Naylor, Rapid diagnosis of MCAD deficiency: quantitative analysis of octanoylcarnitine and other acylcarnitines in newborn blood spots by tandem mass spectrometry, Clin Chem, vol.43, issue.11, pp.2106-2119, 1997.

, Haute Autorité de Santé -Évaluation de l'extension du dépistage néonatal à une ou plusieurs erreurs innées du métabolisme par spectrométrie de masse en tandem. 1er volet: déficit en MCAD

Y. Matsubara, K. Narisawa, and K. Tada, Medium-chain acyl-CoA dehydrogenase deficiency: molecular aspects, Eur J Pediatr, vol.151, issue.3, pp.154-163, 1992.

A. K. Iafolla, R. J. Thompson, and C. R. Roe, Medium-chain acyl-coenzyme A dehydrogenase deficiency: clinical course in 120 affected children, J Pediatr, vol.124, issue.3, pp.409-424, 1994.

S. D. Grosse, M. J. Khoury, C. L. Greene, K. S. Crider, and R. J. Pollitt, The epidemiology of medium chain acyl-CoA dehydrogenase deficiency: an update, Genet Med, vol.8, issue.4, pp.205-217, 2006.

J. L. Merritt and I. J. Chang, Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency

W. J. Rhead, Newborn screening for medium-chain acyl-CoA dehydrogenase deficiency: A global perspective, J Inherit Metab Dis, vol.29, issue.2-3, pp.370-377, 2006.

I. Yokota, P. M. Coates, D. E. Hale, P. Rinaldo, and K. Tanaka, Molecular Survey of a Prevalent Mutation, 985A-to-G Transition, and Identification of Five Infrequent Mutations in the Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Gene in 55 Patients with MCAD Deficiency

, Am. J. Hum. Genet, vol.49, 1991.

D. P. Kelly, J. I. Gordon, R. Alpers, and A. W. Strauss, The tissue-specific expression and developmental regulation of two nuclear genes encoding rat mitochondrial proteins. Medium chain acyl-CoA dehydrogenase and mitochondrial malate dehydrogenase, J Biol Chem, vol.264, issue.32, pp.18921-18926, 1989.

J. Kim, M. Wang, and R. Paschke, Crystal structures of medium-chain acyl-CoA dehydrogenase from pig liver mitochondria with and without substrate, Proc Natl Acad Sci, vol.90, issue.16, pp.7523-7530, 1993.

N. Gregersen, V. Winter, D. Curtis, T. Deufel, M. Mack et al., Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency: The Prevalent Mutation G985 (K304E) Is Subject to a Strong Founder Effect from Northwestern Europe, Hum Hered, vol.43, issue.6, pp.342-50, 1993.

B. Storstein-andresen, S. F. Dobrowolski, J. Muenzer, S. E. Mccandless, D. M. Frazier et al., Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Mutations Identified by MS/MS-Based Prospective Screening of Newborns Differ from Those Observed in Patients with Clinical Symptoms: Identification and Characterization of a New, Prevalent Mutation That Results i

, Am. J. Hum. Genet, vol.68, 2001.

J. M. Jank, E. M. Maier, D. D. Reiß, M. Haslbeck, K. F. Kemter et al., The Domain-Specific and Temperature-Dependent Protein Misfolding Phenotype of Variant Medium-Chain acyl-CoA Dehydrogenase, PLoS One, vol.9, issue.4, p.93852, 2009.

E. M. Maier, S. W. Gersting, K. F. Kemter, J. M. Jank, M. Reindl et al., Protein misfolding is the molecular mechanism underlying MCADD identified in newborn screening, Hum Mol Genet, vol.18, issue.9, pp.1612-1635, 2009.

N. Gregersen, P. Bross, and B. S. Andresen, Genetic defects in fatty acid beta-oxidation and acyl-CoA dehydrogenases. Molecular pathogenesis and genotype-phenotype relationships, Eur J Biochem, vol.271, issue.3, pp.470-82, 2004.

P. Bross, B. S. Andresen, V. Winter, F. Kräutle, T. G. Jensen et al., Co-overexpression of bacterial GroESL chaperonins partly overcomes non-productive folding and tetramer assembly of E. coli-expressed human medium-chain acyl-CoA dehydrogenase (MCAD) carrying the prevalent disease-causing K304E mutation, Biochim Biophys Acta, vol.1182, issue.3, pp.264-74, 1993.

N. Gregersen, B. S. Andresen, and P. Bross, Prevalent mutations in fatty acid oxidation disorders: diagnostic considerations, Eur J Pediatr, vol.159, pp.213-221, 2000.

E. H. Touma and C. Charpentier, Medium chain acyl-CoA dehydrogenase deficiency, Arch Dis Child, vol.67, issue.1, pp.142-147, 1992.

B. Wilcken, J. Hammond, and M. Silink, Morbidity and mortality in medium chain acyl coenzyme A dehydrogenase deficiency, Arch Dis Child, vol.70, issue.5, pp.410-412, 1994.

U. A. Schatz and R. Ensenauer, The clinical manifestation of MCAD deficiency: challenges towards adulthood in the screened population, J Inherit Metab Dis, vol.33, issue.5, pp.513-533, 2010.

M. Duran, M. Hofkamp, W. J. Rhead, J. M. Saudubray, and S. K. Wadman, Sudden child death and "healthy" affected family members with medium-chain acyl-coenzyme A dehydrogenase deficiency, Pediatrics, vol.78, issue.6, pp.1052-1059, 1986.

D. R. De-assis, C. Ribeiro, R. B. Rosa, P. F. Schuck, K. B. Dalcin et al., Evidence that antioxidants prevent the inhibition of Na+,K(+)-ATPase activity induced by octanoic acid in rat cerebral cortex in vitro, Neurochem Res, vol.28, issue.8, pp.1255-63, 2003.

D. Reis-de-assis, M. R. De, C. , B. Rosa, R. Schuck et al., Inhibition of energy metabolism in cerebral cortex of young rats by the medium-chain fatty acids accumulating in MCAD deficiency, Brain Res, vol.1030, issue.1, pp.141-51, 2004.

D. R. De-assis, R. C. Maria, G. C. Ferreira, P. F. Schuck, A. Latini et al., K+ ATPase activity is markedly reduced by cis-4-decenoic acid in synaptic plasma membranes from cerebral cortex of rats, Exp Neurol, vol.197, issue.1, pp.143-152, 2006.

P. F. Schuck, P. C. Ceolato, G. C. Ferreira, A. Tonin, G. Leipnitz et al., Oxidative stress induction by cis-4-decenoic acid: relevance for MCAD deficiency, Free Radic Res, vol.41, issue.11, pp.1261-72, 2007.

P. F. Schuck, C. Ferreira-g-da, A. M. Tonin, C. M. Viegas, E. Busanello et al., Evidence that the major metabolites accumulating in medium-chain acyl-CoA dehydrogenase deficiency disturb mitochondrial energy homeostasis in rat brain, Brain Res, vol.1296, pp.117-143, 2009.

D. A. Trauner, Regional Cerebral Na+K+ ATPase Activity following Octanoate Administration, Pediatr Res, vol.14, issue.6, pp.844-849, 1980.

G. Scaini, K. R. Simon, A. M. Tonin, E. Busanello, A. P. Moura et al., Toxicity of octanoate and decanoate in rat peripheral tissues: evidence of bioenergetic dysfunction and oxidative damage induction in liver and skeletal muscle, Mol Cell Biochem, vol.361, issue.1-2, pp.329-364, 2012.

A. U. Amaral, C. Cecatto, D. Silva, J. C. Wajner, A. Wajner et al., Mechanistic Bases of Neurotoxicity Provoked by Fatty Acids Accumulating in MCAD and LCHAD Deficiencies, J inborn errors Metab Screen, vol.5, pp.1-7, 2017.

T. F. Lang, Adult presentations of medium-chain acyl-CoA dehydrogenase deficiency (MCADD), J Inherit Metab Dis, vol.32, issue.6, pp.675-83, 2009.

F. Feillet, G. Steinmann, C. Vianey-saban, C. De-chillou, N. Sadoul et al., Adult presentation of MCAD deficiency revealed by coma and severe arrythmias, Intensive Care Med, vol.29, issue.9, pp.1594-1601, 2003.

B. Wilcken, K. H. Carpenter, and J. Hammond, Neonatal symptoms in medium chain acyl coenzyme A dehydrogenase deficiency. Arch Dis Child, vol.69, pp.292-296, 1993.

W. R. Treem, C. A. Witzleben, D. A. Piccoli, C. A. Stanley, D. E. Hale et al., Medium-chain and long-chain acyl CoA dehydrogenase deficiency: clinical, pathologic and ultrastructural differentiation from Reye's syndrome, Hepatology, vol.6, issue.6, pp.1270-1278

T. Derks, D. Reijngoud, H. R. Waterham, W. Gerver, M. P. Van-den-berg et al., The natural history of medium-chain acyl CoA dehydrogenase deficiency in the Netherlands: clinical presentation and outcome, J Pediatr, vol.148, issue.5, pp.665-70, 2006.

P. Joy, C. Black, A. Rocca, M. Haas, and B. Wilcken, Neuropsychological functioning in children with medium chain acyl coenzyme a dehydrogenase deficiency (MCADD): the impact of early diagnosis and screening on outcome, vol.15, pp.8-20, 2009.

W. Ruitenbeek, P. J. Poels, D. M. Turnbull, B. Garavaglia, R. A. Chalmers et al., Rhabdomyolysis and acute encephalopathy in late onset medium chain acyl-CoA dehydrogenase deficiency, J Neurol Neurosurg Psychiatry, vol.58, issue.2, pp.209-223, 1995.

L. Santos, A. Patterson, S. M. Moreea, C. M. Lippiatt, J. Walter et al., Acute liver failure in pregnancy associated with maternal MCAD deficiency, J Inherit Metab Dis, vol.30, issue.1, pp.103-103, 2007.

C. Ficicioglu, C. Soler-alfonso, and M. Bennett, Screening for medium-chain acyl CoA dehydrogenase deficiency: current perspectives, Res Reports Neonatol, vol.6, p.1, 2016.

K. Raymond, A. E. Bale, C. A. Barnes, and R. P. , Medium-chain acyl-CoA dehydrogenase deficiency: sudden and unexpected death of a 45 year old woman, Genet Med, vol.1, issue.6, pp.293-297, 1999.

B. Yang, J. Ding, C. Zhou, M. M. Dimachkie, L. Sweetman et al., Identification of a Novel Mutation in Patients with Medium-Chain Acyl-CoA Dehydrogenase Deficiency, Mol Genet Metab, vol.69, issue.3, pp.259-62, 2000.

J. S. Patel and J. Leonard, Ketonuria and medium-chain acyl-CoA dehydrogenase deficiency, J Inherit Metab Dis, vol.18, issue.1, pp.98-107, 1995.

E. Mayatepek, H. G. Koch, and G. F. Hoffmann, Hyperuricaemia and medium-chain acyl-CoA dehydrogenase deficiency, J Inherit Metab Dis, vol.20, issue.6, pp.842-845, 1997.

A. Davidson-mundt, A. S. Luder, and C. L. Greene, Hyperuricemia in medium-chain acyl-coenzyme A dehydrogenase deficiency, J Pediatr, vol.120, issue.3, pp.444-450, 1992.

S. E. Olpin, Implications of impaired ketogenesis in fatty acid oxidation disorders, Prostaglandins Leukot Essent Fat Acids, vol.70, issue.3, pp.293-308, 2004.

M. Duran, G. Mitchell, J. De-klerk, J. P. De-jager, M. Hofkamp et al., Octanoic acidemia and octanoylcarnitine excretion with dicarboxylic aciduria due to defective oxidation of medium-chain fatty acids, J Pediatr, vol.107, issue.3, pp.397-404, 1985.

J. Van-hove, W. Zhang, S. G. Kahler, C. R. Roe, Y. Chen et al., Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency: Diagnosis by Acylcarnitine Analysis in Blood

, Am. J. Hum. Genet, vol.52, 1993.

E. H. Smith, C. Thomas, D. Mchugh, D. Gavrilov, K. Raymond et al., Allelic diversity in MCAD deficiency: The biochemical classification of 54 variants identified during 5years of ACADM sequencing, Mol Genet Metab, vol.100, issue.3, pp.241-50, 2010.

D. Matern and P. Rinaldo, Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency

C. Vianey-liaud, P. Divry, N. Gregersen, and M. Mathieu, The inborn errors of mitochondrial fatty acid oxidation, J Inherit Metab Dis, vol.10, pp.159-200, 1987.

R. G. Boles, E. A. Buck, M. G. Blitzer, M. S. Platt, T. M. Cowan et al., Retrospective biochemical screening of fatty acid oxidation disorders in postmortem livers of 418 cases of sudden death in the first year of life, J Pediatr, vol.132, issue.6, pp.924-957, 1998.

N. Gregersen, S. Kølvraa, K. Rasmussen, P. B. Mortensen, P. Divry et al., General (medium-chain) acyl-CoA dehydrogenase deficiency (non-ketotic dicarboxylic aciduria): quantitative urinary excretion pattern of 23 biologically significant organic acids in three cases, Clin Chim Acta, vol.132, issue.2, pp.181-91, 1983.

M. Duran, D. Klerk, J. B. Wadman, S. K. Bruinvis, L. Ketting et al., The differential diagnosis of dicarboxylic aciduria, J Inherit Metab Dis, vol.7, issue.1, pp.48-51, 1984.

K. Y. Tserng, S. J. Jin, D. S. Kerr, and C. L. Hoppel, Abnormal urinary excretion of unsaturated dicarboxylic acids in patients with medium-chain acyl-CoA dehydrogenase deficiency, J Lipid Res, vol.31, issue.5, pp.763-71, 1990.

P. Rinaldo, J. J. Shea, P. M. Coates, D. E. Hale, C. A. Stanley et al., Medium-Chain Acyl-CoA Dehydrogenase Deficiency, N Engl J Med, vol.319, issue.20, pp.1308-1321, 1988.

P. Rinaldo, J. J. Shea, R. D. Welch, and K. Tanaka, Diagnosis of medium chain acyl-CoA dehydrogenase deficiency by stable isotope dilution analysis of urinary acylglycines: retrospective and prospective studies, and comparison of its accuracy to acylcarnitine identification by FAB/mass spectrometry, Prog Clin Biol Res, vol.321, pp.411-419, 1990.

L. Fisher, C. Davies, O. Y. Al-dirbashi, H. J. Brink, P. Chakraborty et al., A novel method for quantitation of acylglycines in human dried blood spots by UPLC-tandem mass spectrometry, Clin Biochem, vol.54, pp.131-139, 2018.

J. G. Okun, S. Kölker, A. Schulze, D. Kohlmüller, K. Olgemöller et al., A method for quantitative acylcarnitine profiling in human skin fibroblasts using unlabelled palmitic acid: diagnosis of fatty acid oxidation disorders and differentiation between biochemical phenotypes of MCAD deficiency, Biochim Biophys Acta, vol.1584, issue.2-3, pp.91-99, 2002.

D. Bouvier, C. Vianey-saban, S. Ruet, and C. Acquaviva, Development of a Tandem Mass Spectrometry Method for Rapid Measurement of Medium-and Very-Long-Chain Acyl-CoA Dehydrogenase Activity in Fibroblasts, JIMD reports, pp.71-79, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01848150

R. Wanders, J. Ruiter, L. Ijlst, H. R. Waterham, and S. M. Houten, The enzymology of mitochondrial fatty acid beta-oxidation and its application to follow-up analysis of positive neonatal screening results, J Inherit Metab Dis, vol.33, issue.5, pp.479-94, 2010.

R. G. Boles, C. Boesel, and R. P. , Sudden death beyond SIDS, Pediatr Pathol Lab Med, vol.16, issue.4, pp.691-694

J. Zschocke, A. Schulze, M. Lindner, S. Fiesel, K. Olgemöller et al., Molecular and functional characterisation of mild MCAD deficiency, Hum Genet, vol.108, issue.5, pp.404-412, 2001.

H. Autorité-de-santé, Prise en charge en cas de mort inattendue du nourrisson (moins de 2 ans, 2007.

. Acadm, ClinVar -NCBI

N. Gregersen, B. S. Andresen, C. B. Pedersen, R. Olsen, T. J. Corydon et al., Mitochondrial fatty acid oxidation defects-remaining challenges, J Inherit Metab Dis, vol.31, issue.5, pp.643-57, 2008.

E. M. Maier, B. Liebl, W. Röschinger, U. Nennstiel-ratzel, R. Fingerhut et al., Population spectrum of ACADM genotypes correlated to biochemical phenotypes in newborn screening for medium-chain acyl-CoA dehydrogenase deficiency, Hum Mutat, vol.25, issue.5, pp.443-52, 2005.

F. Ter-veld, M. Mueller, S. Kramer, U. Haussmann, D. Herebian et al., A novel tandem mass spectrometry method for rapid confirmation of medium-and very long-chain acyl-CoA dehydrogenase deficiency in newborns, Jul, vol.30, issue.7, p.6449, 2009.

B. S. Andresen, S. F. Dobrowolski, L. O'reilly, J. Muenzer, S. E. Mccandless et al., Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Mutations Identified by MS/MS-Based Prospective Screening of Newborns Differ from Those Observed in Patients with Clinical Symptoms: Identification and Characterization of a New, Prevalent Mutation That Results i, Am J Hum Genet, vol.68, issue.6, pp.1408-1426, 2001.

M. Sturm, D. Herebian, M. Mueller, M. D. Laryea, and U. Spiekerkoetter, Functional Effects of Different Medium-Chain Acyl-CoA Dehydrogenase Genotypes and Identification of Asymptomatic Variants, PLoS One, vol.7, issue.9, p.45110, 2012.

L. O'reilly, P. Bross, T. J. Corydon, S. E. Olpin, J. Hansen et al., The Y42H mutation in medium-chain acyl-CoA dehydrogenase, which is prevalent in babies identified by MS/MSbased newborn screening, is temperature sensitive, Eur J Biochem, vol.271, issue.20, pp.4053-63, 2004.

Y. Matsubara, K. Narisawa, K. Tada, H. Ikeda, Y. Q. Yao et al., Prevalence of K329E mutation in medium-chain acyl-CoA dehydrogenase gene determined from Guthrie cards, Lancet, vol.338, issue.8766, pp.552-555, 1991.

R. Ensenauer, J. L. Winters, P. A. Parton, D. F. Kronn, J. Kim et al., Genotypic differences of MCAD deficiency in the Asian population: novel genotype and clinical symptoms preceding newborn screening notification, Genet Med, vol.7, issue.5, pp.339-382

B. Fromenty, A. Mansouri, J. Bonnefont, F. Courtois, A. Munnich et al., Most cases of medium-chain acyl-CoA dehydrogenase deficiency escape detection in France, Hum Genet, vol.97, issue.3, pp.367-375, 1996.

S. S. Wang, P. M. Fernhoff, W. H. Harnnon, and M. J. Khoury, Medium chain acyl-CoA dehydrogenase deficiency: Human genome epidemiology review, Genet Med, vol.1, issue.7, pp.332-341, 1999.

J. Leonard and C. Dezateux, Newborn screening for medium chain acyl CoA dehydrogenase deficiency, Arch Dis Child, vol.94, issue.3, pp.235-243, 2009.

T. Derks, F. J. Van-spronsen, J. P. Rake, C. S. Van-der-hilst, M. M. Span et al., Safe and unsafe duration of fasting for children with MCAD deficiency, Eur J Pediatr, vol.166, issue.1, pp.5-11, 2007.

J. H. Walter, Tolerance to fast: rational and practical evaluation in children with hypoketonaemia, J Inherit Metab Dis, vol.32, issue.2, pp.214-221, 2009.

C. Touw, G. Smit, K. E. Niezen-koning, C. Bosgraaf-de-boer, A. Gerding et al., In vitro and in vivo consequences of variant medium-chain acyl-CoA dehydrogenase genotypes, Orphanet J Rare Dis, vol.8, issue.1, p.43, 2013.

R. C. Ahrens-nicklas, L. C. Pyle, and C. Ficicioglu, Morbidity and mortality among exclusively breastfed neonates with medium-chain acyl-CoA dehydrogenase deficiency, Genet Med, vol.18, issue.12, pp.1315-1324, 2016.

A. A. Morris and J. Leonard, Early recognition of metabolic decompensation, Arch Dis Child, vol.76, issue.6, pp.555-561, 1997.

C. S. Kim, C. R. Roe, and W. W. Ambrose, l-Carnitine prevents mitochondrial damage induced by octanoic acid in the rat choroid plexus, Brain Res, vol.536, issue.1-2, pp.335-343, 1990.

H. H. Huidekoper, J. Schneider, T. Westphal, F. M. Vaz, M. Duran et al., Prolonged moderate-intensity exercise without and with L-carnitine supplementation in patients with MCAD deficiency, J Inherit Metab Dis, vol.29, issue.5, pp.631-637, 2006.

P. J. Lee, E. L. Harrison, M. G. Jones, S. Jones, J. V. Leonard et al., L-Carnitine and exercise tolerance in medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency: A pilot study, J Inherit Metab Dis, vol.28, issue.2, pp.141-52, 2005.

W. R. Treem, C. A. Stanley, and S. I. Goodman, Medium-chain acyl-CoA dehydrogenase deficiency: metabolic effects and therapeutic efficacy of long-term L-carnitine supplementation, J Inherit Metab Dis, vol.12, issue.2, pp.112-121, 1989.

C. A. Stanley, G. T. Berry, M. J. Bennett, S. M. Willi, W. R. Treem et al., Renal Handling of Carnitine in Secondary Carnitine Deficiency Disorders, Pediatr Res, vol.34, issue.1, pp.89-96, 1993.

T. G. Lucas, B. J. Henriques, J. V. Rodrigues, P. Bross, N. Gregersen et al., Cofactors and metabolites as potential stabilizers of mitochondrial acyl-CoA dehydrogenases, Biochim Biophys Acta -Mol Basis Dis, vol.1812, issue.12, pp.1658-63, 2011.

M. Duran, C. B. Cleutjens, D. Ketting, L. Dorland, J. B. De-klerk et al., Diagnosis of medium-chain acyl-CoA dehydrogenase deficiency in lymphocytes and liver by a gas chromatographic method: the effect of oral riboflavin supplementation, Pediatr Res, vol.31, issue.1, pp.39-42, 1992.

T. Derks, C. Touw, G. S. Ribas, G. B. Biancini, C. S. Vanzin et al., Experimental evidence for protein oxidative damage and altered antioxidant defense in patients with medium-chain acyl-CoA dehydrogenase deficiency, J Inherit Metab Dis, vol.37, issue.5, pp.783-792, 2014.

F. Depeint, W. R. Bruce, N. Shangari, R. Mehta, O. 'brien et al., Mitochondrial function and toxicity: Role of the B vitamin family on mitochondrial energy metabolism, Chem Biol Interact, vol.163, issue.1-2, pp.94-112, 2006.

R. J. Pollitt and J. V. Leonard, Prospective surveillance study of medium chain acyl-CoA dehydrogenase deficiency in the UK. Arch Dis Child, vol.79, pp.116-125, 1998.

L. Feuchtbaum, J. Yang, and R. Currier, Follow-up status during the first 5 years of life for metabolic disorders on the federal Recommended Uniform Screening Panel, Genet Med, vol.20, issue.8, pp.831-840, 2018.

R. Pollitt, A. Green, C. Mccabe, N. Cooper, J. Leonard et al., Neonatal screening for inborn errors of metabolism: cost, yield and outcome

, ):i-iv, Health Technol Assess, issue.7, pp.1-202, 1997.

A. Pandor, J. Eastham, J. Chilcott, S. Paisley, and C. Beverley, Economics of tandem mass spectrometry screening of neonatal inherited disorders, Int J Technol Assess Health Care, vol.22, issue.3, pp.321-327, 2006.

C. S. Van-der-hilst, T. Derks, D. Reijngoud, G. Smit, and E. M. Tenvergert, Cost-effectiveness of neonatal screening for medium chain acyl-CoA dehydrogenase deficiency: the homogeneous population of The Netherlands, J Pediatr, vol.151, issue.2, pp.1-3, 2007.

B. Wilcken, M. Haas, P. Joy, V. Wiley, M. Chaplin et al., Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency in Australia: a cohort study, Lancet, vol.369, issue.9555, pp.37-42, 2007.

M. Lindner, G. Gramer, G. Haege, J. Fang-hoffmann, K. O. Schwab et al., Efficacy and outcome of expanded newborn screening for metabolic diseases -Report of 10 years from South-West Germany *, Orphanet J Rare Dis, vol.6, issue.1, p.44, 2011.

S. Catarzi, A. Caciotti, J. Thusberg, R. Tonin, S. Malvagia et al., Medium-Chain Acyl-CoA Deficiency: Outlines from Newborn Screening, In Silico Predictions, and Molecular Studies. Sci World J, vol.2013, pp.1-8, 2013.

G. Tal, J. Pitt, S. Morrisy, N. Tzanakos, and A. Boneh, An audit of newborn screening procedure: impact on infants presenting clinically before results are available, Mol Genet Metab, vol.114, issue.3, pp.403-411, 2015.

E. A. Jager, M. M. Kuijpers, A. M. Bosch, M. F. Mulder, M. E. Rubio-gozalbo et al., A Nationwide Retrospective Observational Study Of Population Newborn Screening For Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency In The Netherlands, J Inherit Metab Dis, 2019.

K. Tran, S. Banerjee, H. Li, H. Z. Noorani, S. Mensinkai et al., Clinical efficacy and costeffectiveness of newborn screening for medium chain acyl-CoA dehydrogenase deficiency using tandem mass spectrometry, Clin Biochem, vol.40, issue.3-4, pp.235-276, 2007.

L. N. Venditti, C. P. Venditti, G. T. Berry, P. B. Kaplan, E. M. Kaye et al., Newborn Screening by Tandem Mass Spectrometry for Medium-Chain Acyl-CoA Dehydrogenase Deficiency: A Cost-Effectiveness Analysis, Pediatrics, vol.112, issue.5, pp.1005-1020, 2003.

U. Nennstiel-ratzel, S. Arenz, E. M. Maier, I. Knerr, J. Baumkötter et al., Reduced incidence of severe metabolic crisis or death in children with medium chain acyl-CoA dehydrogenase deficiency homozygous for c.985A>G identified by neonatal screening, Mol Genet Metab, vol.85, issue.2, pp.157-166, 2005.

H. Hsu, T. H. Zytkovicz, A. M. Comeau, A. W. Strauss, D. Marsden et al., Spectrum of Medium-Chain Acyl-CoA Dehydrogenase Deficiency Detected by Newborn Screening, Pediatrics, vol.121, issue.5, pp.1108-1122, 2008.

J. L. Dhondt and J. P. Farriaux,

, Ann Biol Clin (Paris), vol.58, issue.3, pp.267-76, 2000.

C. Hirtz and S. Lehmann, Le prélèvement sanguin sur papier buvard : Une révolution de la biologie médicale en marche ?, Ann Biol Clin, vol.73, issue.1, pp.25-37, 2015.

R. Coutant and F. Feillet, Présentation de l'état des lieux du dépistage néonatal en France. médecine/sciences, vol.34, pp.19-21, 2018.

J. Sarles, F. Huet, D. Cheillan, and M. Roussey, Dépistage néonatal en France : quel avenir ? Arch Pédiatrie, vol.21, pp.813-818, 2014.

W. Tu, J. He, H. Chen, X. Shi, and Y. Li, Psychological Effects of False-Positive Results in Expanded Newborn Screening in China, PLoS One, vol.7, p.36235, 2012.

C. Bendavid, D. Cheillan, C. Collet, M. Colombier, C. Corne et al., Guide pour l'accréditation des laboratoires de dépistage néonatal selon la Norme NF EN ISO 15189 -Partie 2 : Phase analytique, 2014.


, Haute Autorité de Santé -Évaluation a priori de l'extension du dépistage néonatal à une ou plusieurs erreurs innées du métabolisme par spectrométrie de masse en tandem

D. Marsden, C. Larson, and H. L. Levy, Newborn screening for metabolic disorders, J Pediatr, vol.148, issue.5, pp.577-584, 2006.

H. Makni, C. St-hilaire, L. Robb, K. Larouche, and I. Blancquaert, Spectrométrie de masse en tandem et dépistage néonatal des erreurs innées du métabolisme : Rapport technique, 2007.

T. Derks, T. S. Boer, A. Van-assen, T. Bos, J. Ruiter et al., Neonatal screening for medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in The Netherlands: the importance of enzyme analysis to ascertain true MCAD deficiency, J Inherit Metab Dis, vol.31, issue.1, pp.88-96, 2008.

S. E. Mccandless, R. Chandrasekar, S. Linard, S. Kikano, and L. Rice, Sequencing from dried blood spots in infants with "false positive" newborn screen for MCAD deficiency, Mol Genet Metab, vol.108, issue.1, pp.51-56, 2013.

L. Waddell, V. Wiley, K. Carpenter, B. Bennetts, L. Angel et al., Medium-chain acyl-CoA dehydrogenase deficiency: Genotype-biochemical phenotype correlations, Mol Genet Metab, vol.87, issue.1, pp.32-41, 2006.

G. L. Arnold, C. A. Saavedra-matiz, P. A. Galvin-parton, R. Erbe, E. Devincentis et al., Lack of genotype-phenotype correlations and outcome in MCAD deficiency diagnosed by newborn screening in New York State, Mol Genet Metab, vol.99, issue.3, pp.263-271, 2010.

K. Bentler, S. Zhai, S. A. Elsbecker, G. L. Arnold, B. K. Burton et al., 221 newbornscreened neonates with medium-chain acyl-coenzyme A dehydrogenase deficiency: Findings from the Inborn Errors of Metabolism Collaborative, Mol Genet Metab, vol.119, issue.1-2, pp.75-82, 2016.

B. Wilcken, Fatty acid oxidation disorders: outcome and long-term prognosis, J Inherit Metab Dis, vol.33, issue.5, pp.501-507, 2010.

R. Yusupov, D. N. Finegold, E. W. Naylor, I. Sahai, S. Waisbren et al., Sudden death in medium chain acyl-coenzyme a dehydrogenase deficiency (MCADD) despite newborn screening, Mol Genet Metab, vol.101, issue.1, pp.33-42, 2010.

C. Touw, G. Smit, M. De-vries, J. De-klerk, A. M. Bosch et al., Risk stratification by residual enzyme activity after newborn screening for medium-chain acyl-CoA dehyrogenase deficiency: data from a cohort study, Orphanet J Rare Dis, vol.7, issue.1, p.30, 2012.

K. Carpenter, V. Wiley, K. G. Sim, D. Heath, and B. Wilcken, Evaluation of newborn screening for medium chain acyl-CoA dehydrogenase deficiency in 275 000 babies. Arch Dis Child -Fetal Neonatal Ed, vol.85, pp.105-109, 2001.

T. H. Zytkovicz, E. F. Fitzgerald, D. Marsden, C. A. Larson, V. E. Shih et al., Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: A two-year summary from the New England newborn screening program, Clin Chem, vol.47, issue.11, pp.1945-55, 2001.

G. A. Horvath, A. Davidson, S. G. Stockler-ipsiroglu, Y. P. Lillquist, P. J. Waters et al., Newborn screening for MCAD deficiency: experience of the first three years in British Columbia, Canada. Can J Public Health, vol.99, issue.4, pp.276-80, 2008.

A. Schulze, M. Lindner, D. Kohlmüller, K. Olgemöller, E. Mayatepek et al., Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: Results, outcome, and implications, Pediatrics, vol.111, issue.6 I, pp.1399-406, 2003.

F. F. Hamers and C. Rumeau-pichon, Cost-effectiveness analysis of universal newborn screening for medium chain acyl-CoA dehydrogenase deficiency in France, BMC Pediatr, vol.12, issue.1, p.60, 2012.

. Gip-resah, Marché public : Fourniture, installation et maintenance de spectromètres de masses en tandem et fourniture de réactifs permettant la réalisation du dépistage néonatal de la phénylcétonurie et du déficit en MCAD -Paris, 2019.

. Chromsystems, Manuel d'utilisation pour le dosage par LC-MS/MS. MassChrom® Acides aminés et acylcarnitines sur sang séché (sans dérivation), 2020.

J. Oerton, J. M. Khalid, G. Besley, R. N. Dalton, M. Downing et al., Newborn screening for medium chain acyl-CoA ehydrogenase deficiency in England: Prevalence, redictive value and test validity based on 1.5 million creened babies

, Journal of Medical Screening, vol.18, pp.173-81, 2011.

B. Wang, Q. Zhang, A. Gao, Q. Wang, J. Ma et al., New Ratios for Performance Improvement for Identifying Acyl-CoA Dehydrogenase Deficiencies in Expanded Newborn Screening: A Retrospective Study. Front Genet, vol.10, p.811, 2019.

C. Lovera, F. Porta, A. Caciotti, S. Catarzi, M. Cassanello et al., Sudden unexpected infant death (SUDI) in a newborn due to medium chain acyl CoA dehydrogenase (MCAD) deficiency with an unusual severe genotype, 2012.

M. L. Couce, P. Sánchez-pintos, L. Diogo, E. Leão-teles, E. Martins et al., Newborn screening for medium-chain acyl-CoA dehydrogenase deficiency: Regional experience and high incidence of carnitine deficiency, Orphanet J Rare Dis, vol.8, issue.1, p.102, 2013.

A. , A. , A. Hertecant, J. L. Al-hamad, S. M. Souid et al., Inborn errors of metabolism in the United Arab Emirates: Disorders detected by newborn screening, JIMD Reports, pp.127-162, 2011.

A. M. Lund, D. M. Hougaard, H. Simonsen, B. S. Andresen, M. Christensen et al., Biochemical screening of 504,049 newborns in Denmark, the Faroe Islands and Greenland -Experience and development of a routine program for expanded newborn screening, Mol Genet Metab, vol.107, issue.3, pp.281-93, 2012.

K. Yokoi, T. Ito, Y. Maeda, Y. Nakajima, A. Ueta et al., Acylcarnitine Profi les during Carnitine Loading and Fasting Tests in a, Japanese Patient with Medium-Chain Acyl-CoA Dehydrogenase Defi ciency, vol.213, 2007.

B. M. Stroup, P. K. Held, P. Williams, M. K. Clayton, S. G. Murali et al., Clinical relevance of the discrepancy in phenylalanine concentrations analyzed using tandem mass spectrometry compared with ion-exchange chromatography in phenylketonuria, Mol Genet Metab Reports, vol.132